Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Cumberland Pharmaceuticals Inc
Cash from Financing Activities
Cumberland Pharmaceuticals Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
|
Cash from Financing Activities
-$7.4m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
2%
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Financing Activities
-$15.8B
|
CAGR 3-Years
-32%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-7%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Financing Activities
-$9.4B
|
CAGR 3-Years
-101%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-24%
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Financing Activities
$26.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Financing Activities
-$4.8B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
18%
|
CAGR 10-Years
2%
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Financing Activities
$3.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Cumberland Pharmaceuticals Inc's Cash from Financing Activities?
Cash from Financing Activities
-7.4m
USD
Based on the financial report for Dec 31, 2023, Cumberland Pharmaceuticals Inc's Cash from Financing Activities amounts to -7.4m USD.
What is Cumberland Pharmaceuticals Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
2%
Over the last year, the Cash from Financing Activities growth was -260%. The average annual Cash from Financing Activities growth rates for Cumberland Pharmaceuticals Inc have been -1% over the past three years , and 2% over the past ten years .